Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Other Accumulated Expenses (2022 - 2025)

Historic Other Accumulated Expenses for Tenon Medical (TNON) over the last 4 years, with Q3 2025 value amounting to $515000.0.

  • Tenon Medical's Other Accumulated Expenses rose 2089.2% to $515000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $515000.0, marking a year-over-year increase of 2089.2%. This contributed to the annual value of $223000.0 for FY2024, which is 304.35% down from last year.
  • Per Tenon Medical's latest filing, its Other Accumulated Expenses stood at $515000.0 for Q3 2025, which was up 2089.2% from $302000.0 recorded in Q2 2025.
  • Tenon Medical's Other Accumulated Expenses' 5-year high stood at $519000.0 during Q1 2024, with a 5-year trough of $209000.0 in Q1 2025.
  • Over the past 4 years, Tenon Medical's median Other Accumulated Expenses value was $302000.0 (recorded in 2025), while the average stood at $343333.3.
  • The largest annual percentage gain for Tenon Medical's Other Accumulated Expenses in the last 5 years was 2089.2% (2025), contrasted with its biggest fall of 5973.03% (2025).
  • Over the past 4 years, Tenon Medical's Other Accumulated Expenses (Quarter) stood at $265000.0 in 2022, then fell by 13.21% to $230000.0 in 2023, then dropped by 3.04% to $223000.0 in 2024, then skyrocketed by 130.94% to $515000.0 in 2025.
  • Its last three reported values are $515000.0 in Q3 2025, $302000.0 for Q2 2025, and $209000.0 during Q1 2025.